| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $343.2M | +14.7% |
| Cost of Revenue | $89.3M | +16.1% |
| Gross Profit | $253.9M | +14.2% |
| R&D Expense | $97.6M | +0.0% |
| SG&A Expense | $64.3M | +0.7% |
| Pre-tax Income | -$85.3M | +7.8% |
| Income Tax | $3.2M | +79.0% |
| Net Income | -$88.5M | +6.1% |
| EPS (Basic) | -$0.67 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $81.1M | -52.7% |
| Short-term Investments | $110.9M | +59.7% |
| Accounts Receivable | $23.4M | -11.1% |
| Current Assets | $256.7M | -15.5% |
| Total Assets | $420.7M | -5.7% |
| Current Liabilities | $164.7M | +14.0% |
| Total Liabilities | $175.3M | +17.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $29.8M | +61.2% |
| Capital Expenditures | $1.6M | -6.0% |
| Investing Cash Flow | -$55.1M | +26.9% |
| Financing Cash Flow | -$65.3M | -227.6% |
| Free Cash Flow | $28.2M | +68.1% |
| +11.8% |
| EPS (Diluted) | -$0.67 | +11.8% |
| Stockholders' Equity |
| $245.3M |
| -17.3% |